Enveric Biosciences (ENVB)
(Delayed Data from NSDQ)
$0.60 USD
-0.03 (-4.51%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.61 +0.01 (1.40%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ENVB 0.60 -0.03(-4.51%)
Will ENVB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ENVB based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ENVB
Is ENVB lining up for a decline? New 52 Week Closing Low shows up after sliding 2.61%
ENVB makes New 52 Week Closing Low on September 18
Enveric Biosciences Closes Warrant Exercise Deal
12 Health Care Stocks Moving In Wednesday's Intraday Session
Enveric Biosciences (ENVB) Showcases Innovative Bioproduction Strategies